Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 88, 106943
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81571325, 81871072, 81301012)
This publication has 32 references indexed in Scilit:
- NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findingsBrain, Behavior, and Immunity, 2017
- Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharideEuropean Journal of Nutrition, 2017
- Differential effects of a short-term high-fat diet in an animal model of depression in rats treated with the 5-HT3 receptor antagonist, ondansetron, the 5-HT3 receptor agonist, 2-methyl-5-HT, and the SSRI, fluoxetinePharmacology Biochemistry and Behavior, 2016
- The role of rhynchophylline in alleviating early brain injury following subarachnoid hemorrhage in ratsBrain Research, 2016
- Alternatively activated microglia and macrophages in the central nervous systemProgress in Neurobiology, 2015
- Synthesis and Protective Effect of Scutellarein on Focal Cerebral Ischemia/Reperfusion in RatsMolecules, 2012
- Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesteraseActa Pharmacologica Sinica, 2011
- Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activationNeuroscience, 2011
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signalingNature Immunology, 2011
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010